What do providers owe patients when a GLP-1 is out of reach? At the very least, they should stay informed.
News|Videos|November 27, 2024
GLP-1 RA antiobesity medications: Patients’ No. 1 question
Author(s)Richard Payerchin
Key Takeaways
- Patients are curious about GLP-1 RA antiobesity medications, necessitating discussions with healthcare providers.
- Dr. Robert Kushner, an expert in obesity and nutrition, stresses the importance of initiating these conversations.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
Advertisement
Advertisement
Related to this article
Panelists at the Sept. 17 briefing said billing codes for two-way shipping and payment for patient navigators are still missing, with most insurers required to cover self-collected HPV tests starting Jan. 1, 2027.
Report: Osteopathic profession leads youth movement as workforce grows across U.S. health care.
From a same-day payment cut to AI-run prior authorization in traditional Medicare, MGMA's government affairs team laid out what Washington has in store for physicians next year.
A multinational survey of more than 1,900 patients with type 2 diabetes or obesity, presented at the EADV Congress 2026, found nail and scalp changes that weight loss alone did not appear to explain.
A Monash University study published in Nature Communications finds that an antibiotic resistance gene lets Clostridioides difficile keep forming spores tough enough to withstand hospital-grade cleaning products and high laundry temperatures.
Behavioral health has historically taken a back seat to physical health in primary care. That approach is shifting, as growing evidence underscores the importance of whole-person well-being in improving patient outcomes, strengthening care coordination and advancing value-based care.
No U.S. state scores even 2 out of 5 on patient sentiment about billing
Advertisement
Advertisement
Trending on Medical Economics
1
GLP-1 users report more nail detachment, hair loss than nonusers, study finds
2
What AI vendor contracts and AI scribe consent mean for physicians' legal risk
3
Six physician groups push back on claims that AI is better informed than doctors
4
The HIPAA and malpractice risks physicians take on with AI tools
5